India: Life Sciences, Biotechnology & Nanotechnology

The Hon’ble Delhi High Court has granted a permanent injunction in favour of the American pharmaceutical and medical devices giant Johnson & Johnson (“J&J”), restraining a New Delhi-based entity from infringing its trademarks ‘Surgicel’, ‘Ligaclip’ and ‘Ethicon’, and from manufacturing, distributing, or selling counterfeit surgical devices. Recognising the grave public health risks posed by counterfeit medical products, the Court also awarded damages amounting to approximately ₹3.34 crore against the defendants.

India's life sciences, pharmaceutical, and consumer healthcare sectors are entering a more enforcement-driven regulatory phase. Recent interventions by the Central Government, the Central Drugs Standard Control...

The Delhi High Court has ruled on a significant patent law question regarding whether making a fungicide stable at high temperatures constitutes an enhancement in efficacy under Section 3(d) of the Patents Act, 1970.

The global medical device industry is undergoing remarkable expansion, driven by technological innovation, rising healthcare demands, and increased investment across markets.

The Government of Karnataka has taken a significant step towards enhancing emergency medical care and protecting Good Samaritans through the promulgation of comprehensive rules under the Karnataka Good Samaritan...

In the past couple of months, India's healthcare and pharmaceutical sectors have undergone a series of structural reforms and policy adjustments, highlighting a clear focus on enhancing patient-centricity, strengthening quality standards, and streamlining regulatory compliance.

The Central Drugs Standard Control Organization (CDSCO) is the National Regulatory Authority (NRA) of India for pharmaceuticals, medical devices, and cosmetics.

Microorganisms are tiny organisms that can only be seen under a microscope. Microorganisms are recognized as the earliest form of life...

In the past couple of months, the healthcare and pharmaceutical sectors have undergone significant regulatory and policy shifts, highlighting a sustained focus on transparency, quality assurance, and industry facilitation.